ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy.

Pedro J Beltran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.